Antihistamines News and Research

RSS
Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

18 Nov 2004
Vaccine provides new hope to the millions of people who suffer from food allergies

Vaccine provides new hope to the millions of people who suffer from food allergies

14 Nov 2004
Kids who outgrow peanut allergy need to eat peanut products at least once a month in order to maintain tolerance

Kids who outgrow peanut allergy need to eat peanut products at least once a month in order to maintain tolerance

11 Nov 2004
Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

26 Sep 2004
Histamine is key to narcolepsy

Histamine is key to narcolepsy

23 Sep 2004
A misconception that eating wasabi decongests the nose

A misconception that eating wasabi decongests the nose

18 Sep 2004
A new lipid-based nasal ointment effective at reducing symptoms of allergic rhinitis

A new lipid-based nasal ointment effective at reducing symptoms of allergic rhinitis

18 Sep 2004
HHS enhances Medicare drug card program to help seniors

HHS enhances Medicare drug card program to help seniors

15 Sep 2004
Research could lead to ways to prevent arrhythmias

Research could lead to ways to prevent arrhythmias

20 Aug 2004
Research will lead to better treatments for mastocytosis

Research will lead to better treatments for mastocytosis

18 Aug 2004
Scopolamine prevents and relieves motion sickness - but possibly with more adverse effects than alternatives

Scopolamine prevents and relieves motion sickness - but possibly with more adverse effects than alternatives

12 Aug 2004
Michigan settlement with pharmaceutical manufacturer Schering Plough

Michigan settlement with pharmaceutical manufacturer Schering Plough

3 Aug 2004
Schering-Ploug will return more than $9 million to the Texas Medicaid program for the company’s fraudulent reporting of prices for drug Claritin

Schering-Ploug will return more than $9 million to the Texas Medicaid program for the company’s fraudulent reporting of prices for drug Claritin

2 Aug 2004
Schering Plough to reimburse Washington's Medicaid program $3.57 million in Claritin case

Schering Plough to reimburse Washington's Medicaid program $3.57 million in Claritin case

31 Jul 2004
Research into hay fever and temperature of the nose rises helps determine how reliable and effective anti-allergic agents are

Research into hay fever and temperature of the nose rises helps determine how reliable and effective anti-allergic agents are

8 Jul 2004
Most over-the-counter cough medications are no better than non-medicated syrup

Most over-the-counter cough medications are no better than non-medicated syrup

6 Jul 2004
62 percent of frequent antihistamine users did not test positive for allergies

62 percent of frequent antihistamine users did not test positive for allergies

28 Jun 2004
Higher generic drug use in 2003 slowed the rising cost per prescription to a 7.9% increase

Higher generic drug use in 2003 slowed the rising cost per prescription to a 7.9% increase

9 Jun 2004
Microbes in your gut could be cause of allergies

Microbes in your gut could be cause of allergies

1 Jun 2004
Antibiotics could be the cause of many allergies

Antibiotics could be the cause of many allergies

27 May 2004

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback